Fulcrum Therapeutics
FULC
#7861
Rank
ยฃ0.18 B
Marketcap
ยฃ3.47
Share price
7.94%
Change (1 day)
-29.89%
Change (1 year)

Revenue for Fulcrum Therapeutics (FULC)

Revenue in 2024 (TTM): ยฃ63.91 Million

According to Fulcrum Therapeutics's latest financial reports the company's current revenue (TTM ) is ยฃ64.46 Million. In 2023 the company made a revenue of ยฃ2.2 Million a decrease over the revenue in the year 2022 that were of ยฃ5.24 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Fulcrum Therapeutics from 2018 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ63.91 M2802.83%
2023 ยฃ2.2 M-58%
2022 ยฃ5.24 M-63.07%
2021 ยฃ14.19 M119.32%
2020 ยฃ6.47 M
2019 N/A
2018 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA